Skip to main content
TipRanks
Go Ultimate75% OFF

TransThera Sciences (Nanjing). Inc. (2617) Financial Statements

5 Followers

TransThera Sciences (Nanjing). Inc. Financial Overview

TransThera Sciences (Nanjing). Inc.'s market cap is currently ¥2.27B. The company's EPS TTM is ¥-1.03; its P/E ratio is -5.98; TransThera Sciences (Nanjing). Inc. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 20
Income Statement
Total Revenue¥ 0.00¥ 0.00¥ 1.18M¥ 124.00K¥ 61.76M
Gross Profit¥ 0.00¥ 0.00¥ 1.18M¥ 124.00K¥ 0.00
Operating Income¥ -300.18M¥ -286.68M¥ -390.52M¥ -312.33M¥ -43.86M
EBITDA¥ -290.82M¥ -267.97M¥ -413.42M¥ 8.55M¥ -39.27M
Net Income¥ -295.96M¥ -274.61M¥ -344.12M¥ -250.04M¥ -80.72M
Balance Sheet
Cash & Short-Term Investments¥ 489.14M¥ 572.53M¥ 838.17M¥ 1.11B¥ 279.34M
Total Assets¥ 545.91M¥ 629.60M¥ 887.09M¥ 1.35B¥ 344.94M
Total Debt¥ 1.65M¥ 4.37M¥ 4.81M¥ 3.04M¥ 490.74M
Net Debt¥ -413.76M¥ -565.14M¥ -491.82M¥ -1.11B¥ 412.54M
Total Liabilities¥ 129.53M¥ 104.57M¥ 103.91M¥ 111.04M¥ 578.87M
Stockholders' Equity¥ 416.38M¥ 525.03M¥ 783.18M¥ 1.24B¥ -233.94M
Cash Flow
Free Cash Flow¥ -253.68M¥ -271.95M¥ -331.12M¥ -244.00M¥ -76.61M
Operating Cash Flow¥ -253.51M¥ -271.18M¥ -319.33M¥ -241.94M¥ -66.68M
Investing Cash Flow¥ -68.00M¥ 348.42M¥ -186.94M¥ 26.98M¥ -195.84M
Financing Cash Flow¥ 169.00M¥ -4.87M¥ 15.76M¥ 240.45M¥ 311.48M

Currency in CNY

TransThera Sciences (Nanjing). Inc. Earnings and Revenue History

-400M-200M0200M-240000 %-160000 %-80000 %0 %EarningsProfit Margin201920202022202320242025RevenueEarningsProfit Margin

TransThera Sciences (Nanjing). Inc. Liabilities to Assets

0500M1B1.5B0 %150 %300 %450 %LiabilitiesLiabilities to Assets201920202022202320242025AssetsLiabilitiesLiabilities to Assets

TransThera Sciences (Nanjing). Inc. Cash Flow

-400M-200M0200M400M201920202022202320242025OperatingInvestingFinancing

TransThera Sciences (Nanjing). Inc. Forecast EPS vs Actual EPS

-0.5-0.5-0.4-0.4-0.3-0.3-0.2-0.2Q2 25Q4 25Q2 26EPS EstimateBeatMiss